02181.HK
Mabpharm Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.43
−1.15%Leverage
- Debt / equity
- 1.59x
- Net debt / equity
- 1.11x
- Debt / assets
- 0.26x
- Debt / EBITDA
- 3.19x
- Net debt / EBITDA
- 2.22x
Liquidity & coverage
- Current ratio
- 0.83x
- Quick ratio
- 0.54x
- Cash ratio
- 0.19x
- Interest coverage
- 3.44x
- EBITDA / interest
- 9.08x
- Working capital
- -HKD 102.7M
Cash & dividend
- FCF / debt
- 0.06x
- Cash flow / debt
- 0.32x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026